Search - tctmd.com

Displaying 61 - 80 of 1757

Sort: Relevancy | Date

Presentation AHA 2017

The POISE-2 PCI Substudy

Presenter: Michelle M. Graham

November 14, 2017

Presentation AHA 2017

Subgroup Analysis from the RE-DUAL PCI Trial

Presenter: Jonas Oldgren

November 14, 2017

News Industry News

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

November 14, 2017

News Conference News AHA 2017

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

Yael L. Maxwell

November 13, 2017

News Conference News AHA 2017

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Michael O'Riordan

November 13, 2017

News Conference News AHA 2017

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Michael O'Riordan

November 13, 2017

Presentation AHA 2017

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Presenter: Steven Weisbord

November 13, 2017

News Conference News AHA 2017

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

Todd Neale

November 12, 2017

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News AHA 2017

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Todd Neale

November 12, 2017

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Todd Neale

November 11, 2017

Presentation AHA 2017

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Presenter: Zuzana Motovska

November 11, 2017

Presentation Cardiovascular Interventions 2017

Current Status of the Bioresorbable Vascular Scaffold: Where the Data is Leading Us

Presenter: David G. Rizik

November 10, 2017

Presentation Cardiovascular Interventions 2017

BP-DES Update: SYNERGY and Beyond

Presenter: Dean J. Kereiakes

November 10, 2017

Presentation Cardiovascular Interventions 2017

Lesion Preparation Prior To Stenting: Rotational Atherectomy

Presenter: Simon walsh

November 10, 2017

Presentation Cardiovascular Interventions 2017

PCI for STEMI Patients With Multivessel Disease: Fix The Culprit or All Lesions?

Presenter: Cindy L. Grines

November 10, 2017

News Daily News

Transradial Access in Primary PCI on the Upswing in the US but Still Uneven

Caitlin E. Cox

November 10, 2017

Presentation Cardiovascular Interventions 2017

Durable Polymer and Polymer-Free DES

Presenter: Ajay J. Kirtane, MD

November 10, 2017

Advertisement

The POISE-2 PCI Substudy

Subgroup Analysis from the RE-DUAL PCI Trial

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI

CANTOS: Big Drop in CVD Events Among Canakinumab Responders

Angiography, Revascularization Safe in Acute MI Patients Taking OACs for Atrial Fibrillation

Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Current Status of the Bioresorbable Vascular Scaffold: Where the Data is Leading Us

BP-DES Update: SYNERGY and Beyond

Lesion Preparation Prior To Stenting: Rotational Atherectomy

PCI for STEMI Patients With Multivessel Disease: Fix The Culprit or All Lesions?

Transradial Access in Primary PCI on the Upswing in the US but Still Uneven

Durable Polymer and Polymer-Free DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content